Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Non-Current Debt (2023 - 2024)

Onconetix (ONCO) has disclosed Non-Current Debt for 2 consecutive years, with $118450.0 as the latest value for Q3 2024.

  • On a quarterly basis, Non-Current Debt changed N/A to $118450.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $118450.0, a N/A change, with the full-year FY2023 number at $118857.0, changed N/A from a year prior.
  • Non-Current Debt was $118450.0 for Q3 2024 at Onconetix, up from $111260.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $462518.0 in Q2 2023 to a low of $110871.0 in Q1 2024.